Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Feher

Orthopaedic Surgery Carmel, IN Medical Doctor

NPI 1932177821 CMS profile 1243503

12188B N Meridian St Ste 250, Carmel, IN 46032

Open in the dashboard

General payments

$7,764

68 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,000 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Anthony Feher of Carmel, IN is reported in the CMS Open Payments database as having received $7,764 across 68 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,000 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 65th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $443 13
2024 General $314 5
2023 General $302 3
2022 General $603 10
2021 General $2,198 20
2020 General $26 2
2019 General $3,877 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Feher
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Anthony Feher were reported at $443. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Anthony Feher Orthopaedic Surgery median Middle half National median
2019 $3,877 $644 $140–$2,844 $163
2020 $26 $312 $75–$1,860 $114
2021 $2,198 $520 $117–$2,495 $132
2022 $603 $598 $128–$2,731 $149
2023 $302 $461 $128–$2,264 $160
2024 $314 $497 $134–$2,475 $164
2025 $443 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $3,232 4 payments
  2. Stryker Corporation $2,488 22 payments
  3. Smith+Nephew, Inc. $503 11 payments
  4. Encore Medical, LP $408 5 payments
  5. Zimmer Biomet Holdings, Inc. $249 5 payments
  6. Osteoremedies, LLC $229 2 payments
  7. Heraeus Medical, LLC. $172 5 payments
  8. KCI USA, Inc $83 1 payment
  9. Onkos Surgical, Inc. $78 1 payment
  10. Heron Therapeutics, Inc. $62 1 payment
  11. Other $259 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $3,150 1 payment
  2. Food and Beverage $2,708 59 payments
  3. Travel and Lodging $1,906 8 payments
Products named General payments · program years 2019–2025
  1. ATTUNE $3,265 5 payments
  2. MAKO $2,401 18 payments
  3. REAL INTELLIGENCE $246 6 payments
  4. JOURNEY II $216 4 payments
  5. LEGION Revision $216 4 payments
  6. DJO SURGICAL $184 2 payments
  7. PALACOS $172 5 payments
  8. Journey Uni $145 1 payment
  9. ROSA Knees $144 1 payment
  10. ROSA Hips $144 1 payment
  11. Other $1,315 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

434

Median for Orthopedic Surgery: 203

Drug cost

$4,621

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 61 $2,105
Oxycodone Hcl Generic 114 $826
Cefadroxil Generic 95 $692
Omeprazole Generic 88 $609
Doxycycline Hyclate Generic 21 $273
Tramadol Hcl Generic 14 $66
Amoxicillin Generic 28 $30
Meloxicam Generic 13 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$48,635

Of which drugs: $180

Medicare patients

124

Average age 73

Services billed

2,071

80 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Depression 24%
Diabetes 23%
Ischemic heart disease 23%
Chronic kidney disease 23%
Atrial fibrillation 17%
Heart failure 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 17 1,760 $177

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

68 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record